5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic and clinical characterization of non-invasive papillary urothelial carcinoma
    Meeting Abstract

    Gurbuz, B. C.; Caraballo, B.; Tallman, J.; Koll, F.; Basar, M.; Chen, J. F.; Sarungbam, J.; Sirintrapun, S. J.; Chen, Y. B.; Gopalan, A.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Spatial profiling of urothelial carcinoma with aberrant histology identified significant intratumoral molecular and immune heterogeneity with clinical implications
    Meeting Abstract

    Kuo, F.; Basar, M.; Koll, F.; Chen, J. F.; Sarungbam, J.; Sirintrapun, S. J.; Chen, Y. B.; Gopalan, A.; Fine, S.; Tickoo, S.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: Results of the phase 3 TiNivo-2 study
    Journal Article

    Choueiri, T. K.; Albiges, L.; Barthélémy, P.; Iacovelli, R.; Emambux, S.; Molina-Cerrillo, J.; Garmezy, B.; Barata, P.; Basu, A.; Bourlon, M. T.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Gene and protein expression of MAGE and associated immune landscape elements in non-small-cell lung carcinoma and urothelial carcinomas
    Journal Article

    Faiena, I.; Adhikary, S.; Schweitzer, C.; Astrow, S. H.; Grogan, T.; Funt, S. A.; Bot, A.; Dorff, T.; Rosenberg, J. E.; Elashoff, D. A.; more...
    Journal of Immunotherapy (2024)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: Extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial
    Journal Article

    Tannir, N. M.; Albigès, L.; McDermott, D. F.; Burotto, M.; Choueiri, T. K.; Hammers, H. J.; Barthélémy, P.; Plimack, E. R.; Porta, C.; George, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
    Journal Article

    Cowzer, D.; Chou, J. F.; Walch, H.; Keane, F.; Khalil, D.; Shia, J.; Do, R. K. G.; Yarmohammadi, H.; Erinjeri, J. P.; El Dika, I.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Cognitive function in long-term testicular cancer survivors: Impact of modifiable factors
    Journal Article

    Dinh, P. C. Jr; Monahan, P. O.; Fung, C.; Sesso, H. D.; Feldman, D. R.; Vaughn, D. J.; Hamilton, R. J.; Huddart, R.; Martin, N. E.; Kollmannsberger, C.; more...
    JNCI Cancer Spectrum (2024)

    Fulltext@MSK | Save
  • Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings
    Research Letter

    Ceyhan-Birsoy, O.; Fiala, E.; Rana, S.; Sheehan, M.; Kennedy, J.; Yelskaya, Z.; Rai, V.; Li, Y.; Yang, C.; Wong, D.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Multivariable models of outcomes with [(177)Lu]Lu-PSMA-617: Analysis of the phase 3 VISION trial
    Journal Article

    Herrmann, K.; Gafita, A.; de Bono, J. S.; Sartor, O.; Chi, K. N.; Krause, B. J.; Rahbar, K.; Tagawa, S. T.; Czernin, J.; El-Haddad, G.; more...
    eClinicalMedicine (2024)

    Fulltext@MSK | Save
  • Direct patient outreach in pediatric neurooncology to improve access to genomic profiling – The make-an-impact program
    Meeting Abstract

    Sait, S. F.; O'Donohue, T.; Hill, K.; Stockfish, E.; Giantini-Larsen, A.; Alano, T.; Bale, T.; Rosenblum, M.; Benhamida, J.; Dunkel, I.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save